Isı Şok Protein İnhibitörü KNK437’nin Endotel Hücrelerinde Anjiyogenez Üzerine Etkisi
Amaç: Hipertermi, kanser ve tümöral anjiyogenez için etkili bir tedavi şeklidir. Ancak, termotolerans gelişimi önemlibir problemdir. Bu çalışmada KNK437 ve quercetinin endotel hücrelerinde anjiyogenez ve termotolerans üzerineetkileri araştırıldı.Yöntem ve gereç: KNK437 veya quercetin ile ön muamele edilmiş olan endotel hücrelerine tek basamaklı ve kademelihipertermi uygulanmıştır. Bu hücrelerde anjiyogenezin incelenmesi için Matrijel Matrikste tüp oluşumu deneyigerçekleştirilmiştir.Bulgular: KNK437 veya quercetin ile 37 °C’de muamele edilmiş olan hücrelerde tüp oluşumunun baskılandığıgörülmüştür. Tek basamaklı hiperterminin (45 °C’de 1 saat) tüp oluşumunu azalttığı görülmüştür. Tüp oluşumu,KNK437 veya quercetin ile ön muamele edilmiş hipertermi grubunda, sadece hipertermi uygulanmış gruba göre düşükbulunmuştur. Kademeli hipertermi grubuna ait tüp uzunluğu anlamlı şekilde yeniden artış göstermiştir. Bununla birlikte,KNK437 veya quercetin ile ön muamele termotoleransın anjiyogenez üzerine olan etkilerini geriye döndürmüştür.Çalışılan tüm deney gruplarında KNK437’nin quercetinden daha etkili olduğu görülmüştür.Sonuç: Bu çalışma, KNK437’nin endotel hücrelerinde anjiyogenez ve termotoleransı inhibe etmesi bakımındanorjinaldir. KNK437 insan metastatik kanserlerinde uygulanan hipertermik tedavinin etkinliğine katkıda bulunabilenesansiyel bir molekül olabilir.
The Effect of KNK437, a Heat Shock Protein lnhibitor, on Angiogenesis of Endothelial Cells
Aim: Hyperthermia is an effective therapy for cancer and tumor angiogenesis. However, the development of thermotolerance is an important problem. We aimed to investigate the effects of KNK437 and quercetin on angiogenesis and thermotolerance in endothelial cells (ECs). Materials and methods: ECs were grown in EGM-2 medium. ECs were preincubated with KNK437 or quercetin and then treated with single and fractionated hyperthermia. Tube formation assay on Matrigel Matrix was performed in these cells to investigate angiogenesis. Results: Tube formation was suppressed in cells that were treated with KNK437 and quercetin at 37 °C. Single hyperthermia (45 °C for 1 h) inhibited tube formation. KNK437 and quercetin pretreatment decreased capillary-like structures more effectively than single hyperthermia treatment. In cells that acquired thermotolerance induced by fractionated hyperthermia, tube formation was dramatically increased, but KNK437 and quercetin reversed the effects of thermotolerance on angiogenesis. KNK437 was found to be more effective than quercetin in all study groups. Conclusion: This study is original in that KNK437 inhibited angiogenesis and thermotolerance in ECs. This compound may be an essential molecule contributing to the efficient treatment of hyperthermic therapy in human cancers.
___
- Dewhirst MW, Prosnitz L, Th rall D, Prescott D, Clegg S, Charles C et al. Hyperthermic treatment of malignant diseases: current status and a view toward the future. Sem Oncol 1997; 24: 616-25. 6. Koishi M, Yokota S, Mae T, Nishimura Y, Kanamori S, Horii N et al. Th e eff ects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo. Clin Cancer Res. 2001; 7: 215-19.
- Yokota S, Kitahara M, Nagata K. Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Res 2000; 60: 2942-48.
- Ohnishi K, Takahashi A, Yokota S, Ohnishi T. Eff ects of a heat shock protein inhibitor KNK437 on heat sensitivity and heat tolerance in human squamous cell carcinoma cell lines diff ering in p53 status. Int J Radiat Biol 2004; 80: 607-14.
- Oh SJ, Kim O, Lee JS, Kim JA, Kim MR, Choi HS et al. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells. Food Chem Toxicol 2010; 48: 3227-34.
- Zhou W, Kallifatidis G, Baumann B, Rausch V, Mattern J, Gladkich J et al. Dietary polyphenol quercetin targets pancreatic cancer stem cells. Int J Oncol 2010; 37: 551-61.
- Pilatova M, Stupakova V, Varinska L, Sarissky M, Mirossay L, Mirossay A et al. Eff ect of selected fl avones on cancer and endothelial cells. Gen Physiol Biophys 2010; 29: 134-43.
- Sahin E, Sahin M, Sanlioglu AD, Gumuslu S. KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic eff ect of hyperthermia. Int J Hyperthermia 2011; 27: 63-73.
- Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
- Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64.
- Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-63.
- O’Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996; 2: 689-92.
- Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
- Sahin M, Sahin E, Gümüşlü S, Erdoğan A, Gültekin M. Inhibition of angiogenesis by S-adenosylmethionine. Biochem Biophys Res Commun 2011; 408: 145-48.
- Hosokawa N, Hirayoshi K, Kudo H, Takechi H, Aoike A, Kawai K, Nagata K. Inhibition of the activation of heat shock factor in vivo and in vitro by fl avonoids. Mol Cell Biol 1992; 12: 3490-98.
- Formica JV, Regelson W. Review of the biology of quercetin and related biofl avonoids. Food Chem Toxicol 1995; 33: 1061- 80.
- Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H et al. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997; 57: 2916-21.
- Igura K, Ohta T, Kuroda Y, Kaji K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 2001; 171: 11-16.
- Shiota M, Kusakabe H, Izumi Y, Hikita Y, Nakao T, Funae Y et al. Heat shock cognate protein 70 is essential for Akt signaling in endothelial function. Arterioscler Th romb Vasc Biol 2010; 30: 491-97.
- Sawaji Y, Sato T, Takeuchi A, Hirata M, Ito A. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Br J Cancer 2002; 86: 1597-1603.
- Milani V, Noessner E. Eff ects of thermal stress on tumor antigenicity and recognition by immune eff ector cells. Cancer Immunol Immunother 2006; 55: 312-19.
- Fajardo LF, Prionas SD. Endothelial cells and hyperthermia. Int J Hyperthermia 1994; 10: 347-53.